Chevy Chase Trust Holdings LLC Buys 6,368 Shares of CVS Health Corporation $CVS

Chevy Chase Trust Holdings LLC lifted its stake in CVS Health Corporation (NYSE:CVS) by 0.9% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 681,685 shares of the pharmacy operator’s stock after acquiring an additional 6,368 shares during the period. Chevy Chase Trust Holdings LLC owned approximately 0.05% of CVS Health worth $47,023,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in CVS. Harbor Asset Planning Inc. bought a new position in shares of CVS Health in the second quarter worth $30,000. Bell Investment Advisors Inc boosted its holdings in shares of CVS Health by 119.8% in the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 248 shares during the period. Roxbury Financial LLC boosted its holdings in shares of CVS Health by 78.3% in the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 202 shares during the period. ORG Partners LLC boosted its holdings in shares of CVS Health by 418.9% in the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 377 shares during the period. Finally, Saudi Central Bank bought a new position in shares of CVS Health in the first quarter worth $34,000. 80.66% of the stock is owned by institutional investors.

Insider Activity

In other news, Director Anne A. Finucane sold 7,500 shares of the firm’s stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the transaction, the director directly owned 22,156 shares of the company’s stock, valued at approximately $1,573,519.12. This trade represents a 25.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 1.22% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on CVS shares. Barclays increased their price objective on CVS Health from $80.00 to $87.00 and gave the stock an “overweight” rating in a research report on Thursday, September 4th. UBS Group upgraded CVS Health from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $67.00 to $79.00 in a research report on Monday, August 18th. Mizuho increased their price objective on CVS Health from $76.00 to $88.00 and gave the stock an “outperform” rating in a research report on Thursday, October 9th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $78.00 price objective on shares of CVS Health in a research report on Tuesday, August 26th. Finally, Wells Fargo & Company increased their price objective on CVS Health from $84.00 to $103.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 7th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $82.57.

CVS Health Trading Up 1.6%

NYSE CVS opened at $82.64 on Friday. The stock’s 50-day simple moving average is $74.00 and its two-hundred day simple moving average is $68.12. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $82.88. The company has a quick ratio of 0.62, a current ratio of 0.80 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $104.81 billion, a price-to-earnings ratio of 23.08, a PEG ratio of 0.90 and a beta of 0.60.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, beating analysts’ consensus estimates of $1.46 by $0.35. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The business had revenue of $98.92 billion for the quarter, compared to the consensus estimate of $94.87 billion. During the same quarter last year, the business posted $1.83 earnings per share. The company’s revenue for the quarter was up 8.4% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Research analysts forecast that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.2%. The ex-dividend date of this dividend is Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is 74.30%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.